Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-15

Clinical Trial Update: University of Utah COVID-19 Hydrochloroquine Trial [Phase 2]

View source ↗

Summary

Phase 2 trial of hydroxychloroquine for coronavirus infections completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University of Utah | Conditions: Coronavirus Infection, Coronavirus | Phase 2 | Status: COMPLETED | Results posted: 2023-02-15